Scholarlink

Purpose of Review <p>To provide the most contemporary evidence, guideline-based recommendations, and future outlook for use of intravascular imaging in percutaneous coronary intervention.</p> Recent Findings <p>New randomized controlled trial and registry data support the use of intravascular imaging to improve hard clinical outcomes, particularly in complex lesion subsets. This data most notably prompted the recent 2024 update to the European Society of Cardiology guidelines – elevating intravascular imaging to a class 1A indication for percutaneous coronary intervention in left main, bifurcation, and long lesions.</p> Summary <p>Intravascular imaging is newly a guideline-based European class 1A recommendation for percutaneous coronary intervention in select complex lesion subsets. While the absolute benefit of intravascular imaging in non-complex lesions is presently unclear, ongoing clinical trial data may ultimately provide evidence to advocate for use in additional clinical settings and perhaps someday all-comer lesions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Intravascular Imaging Guidance During Percutaneous Coronary Intervention: Current Evidence and Future Outlook

  • 期刊论文

  • 发表日期：

    2025年1月23日

查看全文
  • Ilan Vavilin,
  • Yasser Jamil,
  • Jacob McAuliffe,
  • Alexander G. Truesdell

摘要

Purpose of Review

To provide the most contemporary evidence, guideline-based recommendations, and future outlook for use of intravascular imaging in percutaneous coronary intervention.

Recent Findings

New randomized controlled trial and registry data support the use of intravascular imaging to improve hard clinical outcomes, particularly in complex lesion subsets. This data most notably prompted the recent 2024 update to the European Society of Cardiology guidelines – elevating intravascular imaging to a class 1A indication for percutaneous coronary intervention in left main, bifurcation, and long lesions.

Summary

Intravascular imaging is newly a guideline-based European class 1A recommendation for percutaneous coronary intervention in select complex lesion subsets. While the absolute benefit of intravascular imaging in non-complex lesions is presently unclear, ongoing clinical trial data may ultimately provide evidence to advocate for use in additional clinical settings and perhaps someday all-comer lesions.